Skip to main content
Scheduling

Virtual visit appointments available 7 days a week from 9:00am to 11:00pm. Learn More

COVID-19 Updates

COVID-19 Updates: Get the latest on vaccine information, in-person appointments, virtual visits and more. Learn More

Titilope Fasipe, MD, PhD

Location

Texas Medical Center

Specialty
Cancer, Blood Disorders
Phone: 832-822-4362
Fax: 832-825-4362
Email

taishola@texaschildrens.org

Address

6701 Fannin St., Ste. 15210.27
Houston, TX 77030

Titilope Fasipe, MD, PhD

Co-Director, Sickle Cell Program
Assistant Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine

Education

School Education Degree Year
Baylor College of Medicine/Texas Children's Hospital Fellowship Pediatric Hematology/Oncology 2016
Cincinnati Children's Hospital Medical Center Residency Pediatrics 2013
University of Texas Medical Branch Medical School Doctor of Medicine 2010
University of Texas Medical Branch PhD Doctor of Philosophy, Cell Biology-Cancer Track 2010
University of Texas at Arlington Bachelors Bachelor of Science, Biology and Chemistry 2003

About

Dr. Titilope Fasipe's goals are shaped by her desire to help children facing the hardships of a blood disorder. She is intrigued by the clinical challenges of non-malignant hematologic diseases, where in particular, patients with sickle cell disease continue to have significant co-morbid complications and decreased lifespan. Furthermore, she has long been passionate about the psychosocial barriers to care experienced by children with sickle cell, especially during the transitional years.

In addition to Dr. Fasipe's academic role, she is actively involved in various sickle cell-focused community efforts targeted at understanding these challenges. At the state level, she was appointed to the first Texas Sickle Cell Advisory Committee (2016-2018) by the Executive Commissioner of the Texas Health and Human Services. At the local level, she is the current chair of the Houston Sickle Cell Collaborative - a joint effort between the Houston Health Department and organizations vested in sickle cell disease.

She is board certified by the Texas State Board of Medical Examiners and the American Board of Pediatrics in both pediatrics and pediatric hematology.

Clinical Interests
Sickle cell disease and other hemoglobinopathies
General hematology conditions

Organizations

Organization Name Role
Alpha Omega Alpha Honor Medical Society Member
American Academy of Pediatrics (AAP) Member
American Society of Hematology (ASH) Member
American Society of Pediatric Hematology/Oncology (ASPHO) Member
American Society of Pediatric Hematology/Oncology (ASPHO), Hemoglobinopathy Special Interest Group Chair
Children’s Oncology Group (COG) Member
Gold Humanism Honor Society Member

Research Statement

Dr. Fasipe's research interests are focused on understanding barriers to transitioning youth with sickle cell to adult care. She desires to improve readiness to transition through active training and mentorship programs. Additionally, she wants to understand the factors related to patients with high care utilization patterns, in particular those with recurrent pain encounters. Dr. Fasipe is working to provide interventions to help improve pain management and hence, decrease the burden of high utilization. Her work is supported, in part, by a grant from the American College of Emergency Physicians and Pfizer.

Selected Publications

Awards & Honors

2016    Award for Basic Research Poster Presentation, Post-Doctoral Fellow in a Clinical Fellowship, BCM Research & Fellows’ Symposium
2015    American Society of Hematology Abstract Achievement Award
 

Board Certification

American Board of Pediatrics - Pediatrics, American Board of Pediatrics - Hematology/Oncology, Texas State Board of Medical Examiners

Language

English



* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.